Health Department has decided to work with Pfizer to augment proficiency in clinical trials and medical procedures.
The Biopharmaceutical Corporation will train 150 medical researchers under the agreement.
Abu Dhabi (News Update) In view
of the resurgence of corona cases in the country, the UAE, together with
Pfizer, made an important announcement. According to source, Abu Dhabi's health
department has decided to work with Pfizer to enhance expertise in clinical
trials and medical procedures.
The
biopharmaceutical company will train 150 medical researchers under the
agreement. Under the agreement, Pfizer will assist the department in
establishing a training curriculum to advance clinical trials and early stages
of drug development, including research efforts in the UAE. Clinical trials
will be developed to drive and enhance the medical process; participants will
also receive training in technologies and artificial intelligence devices that
accelerate the drug discovery process, aimed at various collaborations and
initiatives. Achieve 500 authoritative medical researchers by 2025.
"We
look forward to working with Pfizer, which focuses on conducting safe and
effective early-stage clinical trials based on international guidelines and
global best practices," said Dr. Jamal Al-Kaabi, Under-Secretary of the
Department. The UAE has one of the most successful CoVID-19 vaccination drives
in the world, with 100% of eligible people receiving their first dose and more
than 90% having received both doses by November.
Since
the epidemic began, the UAE has been working hard to provide vaccines to the
public, as well as to participate in vaccine trials. Last month, the Department
of Health announced the purchase of the drug AZD7442, developed by AstraZeneca.
Which is a new antibody drug to fight infection in high-risk patients?
Dr.
Al-Kaabi said that the Department of Health is committed to position Abu Dhabi
as an incubator for innovation in the field of life sciences and as an important
destination for healthcare in the world, provides that encourages and
encourages research and innovation in healthcare, It expands the means of
collaboration that engages Abu Dhabi with global partners and will continue
promising clinical trials and research projects.
Pfizer correspondent Lindsey Dietschi said: "Abu Dhabi has established a strong and sustainable healthcare system that promotes innovation in research and development. We believe in Abu Dhabi's vision to deliver more medical achievements and to ensure healthy communities."
No comments:
Post a Comment